The California-based biopharmaceutical firm, known for its focus on complex injectable, inhalation, and intranasal products, will provide a live webcast of the session. Interested parties can access the broadcast through the company's investor relations portal at ir.amphastar.com, where it will remain available for replay for 30 days following the event.

Amphastar manages a portfolio that includes proprietary and generic therapies, alongside active pharmaceutical ingredients. Its commercial reach extends through group purchasing organizations, drug wholesalers, and retail distributors. The company maintains a portfolio of registered brands, including BAQSIMI, Primatene MIST, and REXTOVY, as it continues to scale its manufacturing and development pipeline.